Menzies School of Health Research, Institute of Advanced Studies, Charles Darwin University, Darwin, Australia.
BMC Public Health. 2010 Feb 19;10:80. doi: 10.1186/1471-2458-10-80.
There is an overwhelming burden of cardiovascular disease, type 2 diabetes and chronic kidney disease among Indigenous Australians. In this high risk population, it is vital that we are able to measure accurately kidney function. Glomerular filtration rate is the best overall marker of kidney function. However, differences in body build and body composition between Indigenous and non-Indigenous Australians suggest that creatinine-based estimates of glomerular filtration rate derived for European populations may not be appropriate for Indigenous Australians. The burden of kidney disease is borne disproportionately by Indigenous Australians in central and northern Australia, and there is significant heterogeneity in body build and composition within and amongst these groups. This heterogeneity might differentially affect the accuracy of estimation of glomerular filtration rate between different Indigenous groups. By assessing kidney function in Indigenous Australians from Northern Queensland, Northern Territory and Western Australia, we aim to determine a validated and practical measure of glomerular filtration rate suitable for use in all Indigenous Australians.
METHODS/DESIGN: A cross-sectional study of Indigenous Australian adults (target n = 600, 50% male) across 4 sites: Top End, Northern Territory; Central Australia; Far North Queensland and Western Australia. The reference measure of glomerular filtration rate was the plasma disappearance rate of iohexol over 4 hours. We will compare the accuracy of the following glomerular filtration rate measures with the reference measure: Modification of Diet in Renal Disease 4-variable formula, Chronic Kidney Disease Epidemiology Collaboration equation, Cockcroft-Gault formula and cystatin C- derived estimates. Detailed assessment of body build and composition was performed using anthropometric measurements, skinfold thicknesses, bioelectrical impedance and a sub-study used dual-energy X-ray absorptiometry. A questionnaire was performed for socio-economic status and medical history.
We have successfully managed several operational challenges within this multi-centre complex clinical research project performed across remote North, Western and Central Australia. It seems unlikely that a single correction factor (similar to that for African-Americans) to the equation for estimated glomerular filtration rate will prove appropriate or practical for Indigenous Australians. However, it may be that a modification of the equation in Indigenous Australians would be to include a measure of fat-free mass.
心血管疾病、2 型糖尿病和慢性肾病在澳大利亚原住民中负担沉重。在这个高危人群中,准确测量肾功能至关重要。肾小球滤过率是肾功能的最佳整体标志物。然而,澳大利亚原住民和非原住民在体型和身体成分方面存在差异,这表明为欧洲人群开发的基于肌酐的肾小球滤过率估计值可能并不适合澳大利亚原住民。肾脏病的负担不成比例地由澳大利亚中部和北部的原住民承担,并且这些群体内部和之间的体型和成分存在显著的异质性。这种异质性可能会对不同原住民群体之间肾小球滤过率估计的准确性产生不同的影响。通过评估来自昆士兰北部、北领地和西澳大利亚的原住民的肾功能,我们旨在确定一种适用于所有原住民的经过验证和实用的肾小球滤过率测量方法。
方法/设计:这是一项针对澳大利亚原住民成年人(目标样本量为 600 人,其中 50%为男性)的横断面研究,在 4 个地点进行:北领地的顶端地区;澳大利亚中部;北昆士兰州和西澳大利亚。肾小球滤过率的参考测量方法是 4 小时内 iohexol 的血浆清除率。我们将比较以下肾小球滤过率测量方法与参考测量方法的准确性:改良肾脏病饮食研究 4 变量公式、慢性肾脏病流行病学合作方程、 Cockcroft-Gault 公式和胱抑素 C 衍生的估计值。使用人体测量学测量、皮褶厚度、生物电阻抗和子研究使用双能 X 射线吸收法对体型和身体成分进行了详细评估。还进行了一份关于社会经济地位和病史的问卷。
我们已经成功地管理了这个在偏远的北澳、西澳和中澳进行的多中心复杂临床研究项目中的几个运营挑战。似乎不太可能有一种单一的校正因子(类似于非裔美国人的校正因子)适用于或适用于澳大利亚原住民的估计肾小球滤过率方程。然而,可能需要对澳大利亚原住民的方程进行修改,以纳入无脂肪质量的测量值。